Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Increasing business profitability involves strategic adjustments. Learn actionable ways to enhance your profits and ensure long-term success.
18,600 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
SpaceX just shook the investor world again with a massive bond offering. This article breaks down what spacex's fundr...
Credo Technology rides a surge in AI infrastructure demand, but the path to $500 by 2030 hinges on durable revenue gr...
NVIDIA is set to report quarterly results as investors wrestle with hype around AI. Analysts forecast strong growth b...
As miners shift capital from BTC holdings to AI compute, the landscape for there bitcoin mining stocks changes. This ...
The Nasdaq Composite extended gains as bulls maintain control amid stronger tech deal activity, improving chip profit...
Dutch Bros has grown from a regional coffee shop to a national sensation. This article weighs the case for dutch bros...
Wells Fargo lowers Amazon's price target to $312 while keeping an Overweight rating, highlighting AWS as the core eng...
A practical guide to interpreting a 2026 earnings transcript. Discover what the numbers, guidance, and management com...
A quiet international fund is flashing some of the strongest gains in 2026. Schwab’s international ETF has climbed sh...
SpaceX is expanding fast after its IPO, but new debt plans and strategic bets raise questions for investors. This art...
Starboard Value’s effort at Dynatrace tests whether the observability software maker can turn around on its own or be...